Two Doses Of Recombinant Zoster Vaccine Provide Strong Protection Against Shingles, Study Indicates

Healio (1/8, Rhoades) reports, “Two doses of the recombinant zoster vaccine provided strong protection over 4 years, even in patients taking corticosteroids who are at higher risk for herpes zoster, also known as shingles, according to researchers.” The findings were published in Annals of Internal Medicine.